Monitoring instead of surgery could be a viable option for a sub-population of young women with moderate pre-invasive cervical lesions. Organised cervical screening is aimed at detection of pre-invasive lesions (cervical intraepithelial neoplasia, CIN), where the grade of the pre-cancerous abnormality determines management options. CIN1 is almost always managed conservatively in young women, while CIN3 […]
Despite providing significant contributions to patient care on daily basis, non-medical health professionals often struggle to establish an academic research career, often due to limited support opportunities. In order to increase the number of nurses, allied health professionals (AHPs), pharmacists, and healthcare scientists engaging in clinical academic research within the Imperial College Academic Health Science […]
NIHR Senior Investigator (SI) awards recognise some of the country’s foremost clinical and biomedical scientists, making significant leadership contributions to clinical, applied health and social care research. Following the 11th national competition, an independent expert panel advised the appointment of 43 new NIHR SIs, 12 re-appointments, and 34 new Emeritus SIs. The following Imperial BRC […]
In addition to being a traumatic experience, pre-term birth and its complications are the leading cause of death in children under 5 years old, worldwide. In approximately 30% of cases, pre-term labour is preceded by the rupture of fetal membranes (referred to as ‘PPROM’) prior to 37 weeks of pregnancy. One hypothesis for the cause […]
An increasing number of innovative ideas are being turned into commercialised products and spin-out companies every year. In 2016-17, the Faculty of Medicine generated 92 invention disclosures involving 79 academics from across our 5 Departments. To celebrate Imperial Enterprise Week – a week-long showcase of start-ups, entrepreneurs and innovators from across the Imperial community – […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.